once again we give a small company a huge leg up while our sp dives, we are like the st vincent de paul of the asx! of course thinking long term this is all great news but in the short term its just the same old story.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
